NGUYEN ANH TU (See Remarks) received a stock award from XERIS BIOPHARMA HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/2/2026ACC: 0002058704-26-000002
Officer· See Remarks
Since Feb 2026
+283.45K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
283.45K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+121.29K
Price / share
—
Trade value
—
% of position
40.0%
1/30/2026
303.03K→424.32K
Total
Net shares
+121.29K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/30/2026 | A · Award | +121.29K | — | — | 40.0% | 303.03K | 424.32K |
| Total | +121.29K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
162.16K shares
Shares
+162.16K
Strike price
7.36
Held after
162.16K
Exercisable
—
1/30/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock162.16K shares | 1/30/2026 | A · Award | +162.16K | 7.36 | — | 162.16K |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned3.50K
Common Stock
IndirectShares owned3.71K
Total
7.21K indirect7.21K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.50K | Indirect |
| Common Stock | 3.71K | Indirect |
| Total | 7.21K | 7.21K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported